Skip to main content
. 2020 Jun 16;11(24):2273–2289. doi: 10.18632/oncotarget.27593

Figure 2. GRB7 expression in benign fibroadenoma and fibrocystic changes.

Figure 2

Examples of images of benign breast cancer tumors stained with the GRB7 antibody (brown) and Hematoxylin (blue). (A) Benign fibroadenoma tissue showing high GRB7 expression (3+) in myoepithelial cells. (B) Benign fibrocystic changes showing no GRB7 expression (0). Images were taken with a 40 × objective, scale bar = 50 μm).